Exercise has long been recognized as beneficial for cancer survivors, but new research from Edith Cowan University in Australia provides compelling evidence about how even a single workout session might help protect against cancer recurrence. The study, published in Breast Cancer Research and Treatment, reveals that both resistance training and high-intensity interval training can trigger the body to produce cancer-fighting molecules and suppress cancer cell growth.
The Science Behind Exercise and Cancer Protection
When we exercise, our muscles act as more than just motors for movement. They function as endocrine organs, releasing signaling molecules called myokines into the bloodstream. These myokines serve various functions throughout the body, and mounting evidence suggests that some of them possess anti-cancer properties. Previous research has shown that myokines like interleukin-6, decorin, and others can inhibit cancer cell growth, promote cancer cell death, and potentially reduce the risk of cancer recurrence.
Until now, most studies examining these effects have been conducted in healthy individuals or animal models, limiting their direct application to cancer survivors. This new research addresses that gap by studying breast cancer survivors specifically, providing more relevant insights for this population.
What the Researchers Did
The research team recruited 32 breast cancer survivors who had completed their primary treatment at least four months prior. These women were randomly assigned to perform either a single session of resistance training or high-intensity interval training. The resistance training group performed exercises targeting major muscle groups, including chest presses, leg presses, and rowing movements. The high-intensity interval training group alternated between short bursts of intense exercise and recovery periods using equipment like stationary bikes and treadmills.
Blood samples were collected at three critical time points: before exercise, immediately after, and 30 minutes post-exercise. The researchers then measured levels of four key myokines known for their anti-cancer properties. Perhaps most importantly, they tested whether serum from the exercised participants could suppress the growth of aggressive breast cancer cells in laboratory conditions.
Remarkable Findings from a Single Workout
The results were striking. Both forms of exercise triggered significant increases in anti-cancer myokines, with levels rising between 9 and 47 percent immediately after exercise. Some of these beneficial molecules remained elevated even 30 minutes after the workout ended. When the researchers exposed breast cancer cells to the post-exercise serum, they observed a significant reduction in cancer cell growth ranging from 19 to 29 percent compared to baseline.
While both exercise types proved effective, high-intensity interval training showed slightly stronger effects on certain markers, particularly interleukin-6 levels and immediate cancer cell suppression. However, both forms of exercise demonstrated meaningful anti-cancer effects, suggesting that the type of exercise may be less important than simply engaging in moderate to vigorous physical activity.
What This Means for Breast Cancer Survivors
These findings carry important implications for the millions of women worldwide who have survived breast cancer. With recurrence rates ranging from 10 to 30 percent depending on various factors, identifying accessible strategies to reduce this risk is crucial. This research suggests that exercise represents a powerful, non-pharmacological tool that survivors can use to potentially protect themselves against cancer recurrence.
The fact that even a single exercise session can produce these effects is particularly encouraging. While the long-term impacts of regular exercise on cancer recurrence require further study, this research provides a biological mechanism that helps explain why physically active cancer survivors tend to have better outcomes than their sedentary counterparts.
Moving Forward
This study represents an important step in understanding how exercise fights cancer at the cellular level. The researchers tested their approach using triple-negative breast cancer cells, an aggressive form of the disease that lacks hormone receptors and is particularly challenging to treat. The fact that exercise-conditioned serum could suppress even these resistant cells underscores the potential power of physical activity as a complementary cancer therapy.
For breast cancer survivors wondering how to incorporate these findings into their lives, the message is clear: regular physical activity, whether through resistance training or high-intensity intervals, appears to trigger beneficial biological responses that may help keep cancer at bay. While more research is needed to determine optimal exercise prescriptions and long-term effects, this study provides compelling evidence that exercise truly functions as medicine in the fight against cancer.
The research also highlights the importance of viewing exercise not just as a tool for improving fitness or managing weight, but as a therapeutic intervention with direct anti-cancer effects. As we continue to understand the complex relationship between physical activity and cancer biology, exercise prescription may become an increasingly important component of comprehensive cancer care.
